Core-shell lipid-polymeric nanoparticles for enhanced oral bioavailability and antihypertensive efficacy of KY5 peptide
oral、bioavailability、core-shell、efficacy、enhanced、hypertensive、lipid-polymeric、nanoparticles、peptide
34
R781.4;TM910.3;O643
2023-06-08(万方平台首次上网日期,不代表论文的发表时间)
共6页
158-163